D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Biology and Biochemistry D-index 76 Citations 21,240 256 World Ranking 2160 National Ranking 1195

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Enzyme
  • Amino acid

Kermit L. Carraway spends much of his time researching Cell biology, Receptor tyrosine kinase, Biochemistry, Cancer research and ERBB3. Kermit L. Carraway interconnects Receptor, Transmembrane protein, Cell and Glycoprotein complex in the investigation of issues within Cell biology. His Receptor tyrosine kinase study combines topics from a wide range of disciplines, such as ROR1, Tyrosine kinase, Neuregulin and ErbB.

His Biochemistry study deals with Chromatography intersecting with Guanidine, Ascites and Mammary adenocarcinoma. His work deals with themes such as Breast cancer, Trastuzumab, Antibody, Immunology and Transfection, which intersect with Cancer research. His study in ERBB3 is interdisciplinary in nature, drawing from both Epidermal growth factor, ERBB4 and Ubiquitin ligase.

His most cited work include:

  • Catalytic specificity of protein-tyrosine kinases is critical for selective signalling (829 citations)
  • Vascular Dysmorphogenesis Caused by an Activating Mutation in the Receptor Tyrosine Kinase TIE2 (655 citations)
  • INSECT CELL-EXPRESSED P180ERBB3 POSSESSES AN IMPAIRED TYROSINE KINASE ACTIVITY (630 citations)

What are the main themes of his work throughout his whole career to date?

His scientific interests lie mostly in Cell biology, Biochemistry, Receptor tyrosine kinase, Cancer research and Molecular biology. The concepts of his Cell biology study are interwoven with issues in Receptor, Transmembrane protein, Cell and Mucin. While the research belongs to areas of Transmembrane protein, Kermit L. Carraway spends his time largely on the problem of Glycoprotein complex, intersecting his research to questions surrounding Endocrinology and Internal medicine.

His work carried out in the field of Receptor tyrosine kinase brings together such families of science as ROR1, Tyrosine kinase, Neuregulin and ErbB. His research in Cancer research intersects with topics in Cancer, Breast cancer, Metastasis, Tumor progression and Immunology. His work in Signal transduction covers topics such as Cell surface receptor which are related to areas like Epidermal growth factor.

He most often published in these fields:

  • Cell biology (42.03%)
  • Biochemistry (29.57%)
  • Receptor tyrosine kinase (22.32%)

What were the highlights of his more recent work (between 2010-2020)?

  • Cell biology (42.03%)
  • Cancer research (15.65%)
  • Signal transduction (13.04%)

In recent papers he was focusing on the following fields of study:

Kermit L. Carraway focuses on Cell biology, Cancer research, Signal transduction, Receptor tyrosine kinase and Ubiquitin ligase. The various areas that Kermit L. Carraway examines in his Cell biology study include Cell and Apoptosis-inducing factor. The study incorporates disciplines such as Cancer, Breast cancer, Metastasis and Apoptosis, Programmed cell death in addition to Cancer research.

His Receptor tyrosine kinase study improves the overall literature in Receptor. His Ubiquitin ligase research includes elements of ERBB3 and Focal adhesion. Tyrosine kinase is a subfield of Biochemistry that Kermit L. Carraway studies.

Between 2010 and 2020, his most popular works were:

  • Galectin-3 Regulates Intracellular Trafficking of EGFR through Alix and Promotes Keratinocyte Migration (66 citations)
  • Lrig1 is an estrogen-regulated growth suppressor and correlates with longer relapse-free survival in ERα-positive breast cancer. (51 citations)
  • CD44 interacts with EGFR and promotes head and neck squamous cell carcinoma initiation and progression (51 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Enzyme
  • Amino acid

Kermit L. Carraway mainly investigates Cell biology, Signal transduction, Receptor tyrosine kinase, Cancer research and Tumor progression. His studies in Cell biology integrate themes in fields like Cell migration and Endoplasmic-reticulum-associated protein degradation. Kermit L. Carraway has researched Signal transduction in several fields, including Receptor, Cell surface receptor, Endocytosis and Endosome.

His study brings together the fields of Breast cancer and Receptor tyrosine kinase. His Cancer research study which covers Cell growth that intersects with Epithelial–mesenchymal transition, Cell culture and Immunology. His work deals with themes such as Epidermal growth factor, Ubiquitin ligase and Phosphorylation, Focal adhesion, which intersect with Tumor progression.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Catalytic specificity of protein-tyrosine kinases is critical for selective signalling

Zhou Songyang;Zhou Songyang;Kermit L. Carraway;Michael J. Eck;Stephen C. Harrison.
Nature (1995)

1093 Citations

INSECT CELL-EXPRESSED P180ERBB3 POSSESSES AN IMPAIRED TYROSINE KINASE ACTIVITY

Pamela M. Guy;Jill V. Platko;Lewis C. Cantley;Richard A. Cerione.
Proceedings of the National Academy of Sciences of the United States of America (1994)

979 Citations

A neu acquaintance for ErbB3 and ErbB4: A role for receptor heterodimerization in growth signaling

Kermit L. Carraway;Kermit L. Carraway;Lewis C. Cantley;Lewis C. Cantley.
Cell (1994)

935 Citations

Vascular Dysmorphogenesis Caused by an Activating Mutation in the Receptor Tyrosine Kinase TIE2

Miikka Vikkula;Laurence M Boon;Kermit L.Carraway;Jennifer T Calvert.
Cell (1996)

839 Citations

Neuregulin-2, a new ligand of ErbB3/ErbB4-receptor tyrosine kinases

Kermit L. Carraway;Janet L. Weber;Michelle J. Unger;Jessica Ledesma.
Nature (1997)

580 Citations

A Comparative Analysis of the Phosphoinositide Binding Specificity of Pleckstrin Homology Domains

Lucia E. Rameh;Ann Kristin Arvidsson;Kermit L Carraway;Anthony D. Couvillon.
Journal of Biological Chemistry (1997)

579 Citations

Decreased Accessibility and Lack of Activation of ErbB2 in JIMT-1, a Herceptin-Resistant, MUC4-Expressing Breast Cancer Cell Line

Peter Nagy;Elza Friedländer;Minna Tanner;Anita I. Kapanen.
Cancer Research (2005)

574 Citations

ErbB3 is involved in activation of phosphatidylinositol 3-kinase by epidermal growth factor.

Stephen P. Soltoff;Kermit L Carraway;S. A. Prigent;W. G. Gullick.
Molecular and Cellular Biology (1994)

523 Citations

The erbB3 gene product is a receptor for heregulin.

K.L. Carraway rd;M.X. Sliwkowski;R. Akita;J.V. Platko.
Journal of Biological Chemistry (1994)

507 Citations

Met receptor contributes to trastuzumab resistance of Her2-overexpressing breast cancer cells.

David L. Shattuck;Jamie K. Miller;Kermit L Carraway;Colleen A Sweeney.
Cancer Research (2008)

449 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Kermit L. Carraway

Surinder K. Batra

Surinder K. Batra

University of Nebraska Medical Center

Publications: 103

Yosef Yarden

Yosef Yarden

Weizmann Institute of Science

Publications: 72

Donald Kufe

Donald Kufe

Harvard University

Publications: 64

Miikka Vikkula

Miikka Vikkula

KU Leuven

Publications: 57

Isabelle Van Seuningen

Isabelle Van Seuningen

University of Lille

Publications: 39

Lewis C. Cantley

Lewis C. Cantley

Cornell University

Publications: 34

Sandra J. Gendler

Sandra J. Gendler

Mayo Clinic

Publications: 32

Mark A. Lemmon

Mark A. Lemmon

Yale University

Publications: 30

John Kuriyan

John Kuriyan

University of California, Berkeley

Publications: 29

Erik P. Lillehoj

Erik P. Lillehoj

University of Maryland, Baltimore

Publications: 29

Ilene K. Gipson

Ilene K. Gipson

Harvard Medical School

Publications: 28

Michael A. Hollingsworth

Michael A. Hollingsworth

University of Nebraska Medical Center

Publications: 28

John B. Mulliken

John B. Mulliken

Boston Children's Hospital

Publications: 26

William J. Muller

William J. Muller

McGill University

Publications: 24

Nancy E. Hynes

Nancy E. Hynes

Friedrich Miescher Institute

Publications: 24

Mien Chie Hung

Mien Chie Hung

China Medical University

Publications: 23

Something went wrong. Please try again later.